NO319583B1 - Gel for sarbehandling og fremstilling av denne - Google Patents
Gel for sarbehandling og fremstilling av denne Download PDFInfo
- Publication number
- NO319583B1 NO319583B1 NO19994242A NO994242A NO319583B1 NO 319583 B1 NO319583 B1 NO 319583B1 NO 19994242 A NO19994242 A NO 19994242A NO 994242 A NO994242 A NO 994242A NO 319583 B1 NO319583 B1 NO 319583B1
- Authority
- NO
- Norway
- Prior art keywords
- gel
- sodium
- carboxy
- acid derivative
- polysaccharide
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 10
- 206010052428 Wound Diseases 0.000 claims description 26
- 208000027418 Wounds and injury Diseases 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 26
- 229920001282 polysaccharide Polymers 0.000 claims description 21
- 239000005017 polysaccharide Substances 0.000 claims description 21
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical group O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 19
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 17
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 16
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 16
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 16
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 12
- 229920002230 Pectic acid Polymers 0.000 claims description 11
- 150000002500 ions Chemical class 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000010318 polygalacturonic acid Substances 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 239000000783 alginic acid Substances 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- 229960001126 alginic acid Drugs 0.000 claims description 5
- 229940121375 antifungal agent Drugs 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- -1 carboxy polysaccharide Chemical class 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 229960004063 propylene glycol Drugs 0.000 claims description 4
- 235000013772 propylene glycol Nutrition 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004146 Propane-1,2-diol Substances 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 102000016943 Muramidase Human genes 0.000 claims description 2
- 108010014251 Muramidase Proteins 0.000 claims description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 239000003193 general anesthetic agent Substances 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 229960000274 lysozyme Drugs 0.000 claims description 2
- 239000004325 lysozyme Substances 0.000 claims description 2
- 235000010335 lysozyme Nutrition 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 150000002009 diols Chemical class 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000000499 gel Substances 0.000 description 49
- 229920000642 polymer Polymers 0.000 description 29
- 239000000017 hydrogel Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 7
- 229910001628 calcium chloride Inorganic materials 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 5
- 229910001424 calcium ion Inorganic materials 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000004436 sodium atom Chemical group 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010006802 Burns second degree Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000010346 polypectate Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9704807A GB2322864A (en) | 1997-03-07 | 1997-03-07 | Gel for application to the human or animal body |
| PCT/GB1998/000494 WO1998040110A1 (en) | 1997-03-07 | 1998-03-05 | Wound dressing gel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO994242D0 NO994242D0 (no) | 1999-09-01 |
| NO994242L NO994242L (no) | 1999-11-08 |
| NO319583B1 true NO319583B1 (no) | 2005-08-29 |
Family
ID=10808905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19994242A NO319583B1 (no) | 1997-03-07 | 1999-09-01 | Gel for sarbehandling og fremstilling av denne |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6251424B1 (de) |
| EP (1) | EP0968009B1 (de) |
| JP (1) | JP2002501406A (de) |
| AU (1) | AU6627898A (de) |
| CA (1) | CA2283483C (de) |
| DE (1) | DE69817782T2 (de) |
| DK (1) | DK0968009T3 (de) |
| ES (1) | ES2206899T3 (de) |
| GB (1) | GB2322864A (de) |
| NO (1) | NO319583B1 (de) |
| WO (1) | WO1998040110A1 (de) |
| ZA (1) | ZA981908B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005023323A1 (en) * | 2003-09-08 | 2005-03-17 | Fmc Biopolymer As | Gelled biopolymer based foam |
| GB2409974A (en) * | 2004-01-14 | 2005-07-20 | Avanticare Ltd | Gel comprising citrus complex carbohydrates for the application to a wound |
| CA2615368A1 (en) * | 2005-07-15 | 2007-01-25 | Tyco Healthcare Group Lp | Wound dressing and methods of making and using the same |
| CN100500227C (zh) * | 2006-10-23 | 2009-06-17 | 厦门大学 | 骨骼粘合剂的粘合方法 |
| CN100435858C (zh) * | 2006-10-23 | 2008-11-26 | 厦门大学 | 海藻酸钠-羧甲基纤维素复合骨骼粘合剂及其制备方法 |
| WO2016081820A1 (en) * | 2014-11-20 | 2016-05-26 | University Of Southern California | Use of alginate formulation for intraincisional drug delivery |
| US20200061193A1 (en) * | 2017-05-12 | 2020-02-27 | Corning Incorporated | A cross-linked shear thinning fluid with tunable rheology for 3d bioprinting and drug delivery |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2726982A (en) * | 1950-05-24 | 1955-12-13 | Irving L Ochs | Hydrous gels |
| US4226232A (en) | 1979-04-09 | 1980-10-07 | Spenco Medical Corporation | Wound dressing |
| US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
| ATE82511T1 (de) * | 1982-04-22 | 1992-12-15 | Squibb & Sons Inc | Granulate zur verwendung bei der behandlung von wunden. |
| US4604384A (en) | 1982-06-24 | 1986-08-05 | Smith Robert A | Pharmaceutical gel composition |
| DE3226753A1 (de) | 1982-07-14 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Wundverband zur aufnahme von wundsekret |
| US4618491A (en) | 1984-06-05 | 1986-10-21 | Daicel Chemical Industries Ltd. | Stable gel composition containing a carboxymethyl cellulose salt and a process for the preparation of them |
| US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| SE457770B (sv) | 1985-05-23 | 1989-01-30 | Pharmacia Ab | Foerfarande foer att stabilisera en vattenhaltig dispersion av vattenabasorberade partiklar |
| GB8515170D0 (en) | 1985-06-14 | 1985-07-17 | Geistlich Soehne Ag | Pharmaceutical compositions |
| DK154806C (da) | 1986-12-19 | 1989-06-26 | Coloplast As | Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf |
| US4956350A (en) | 1988-08-18 | 1990-09-11 | Minnesota Mining And Manufacturing Company | Wound filling compositions |
| US5089606A (en) | 1989-01-24 | 1992-02-18 | Minnesota Mining And Manufacturing Company | Water-insoluble polysaccharide hydrogel foam for medical applications |
| US5073202A (en) | 1989-03-09 | 1991-12-17 | Micro Vesicular Systems, Inc. | Method of using a biodegradable superabsorbing sponge |
| GB8921658D0 (en) | 1989-09-26 | 1989-11-08 | Mars G B Ltd | Gelling systems |
| GB2255705B (en) * | 1989-09-26 | 1993-10-13 | Mars G B Ltd | Gelling system |
| GB9105995D0 (en) | 1991-03-21 | 1991-05-08 | Smith & Nephew | Wound dressing |
| WO1993010157A1 (en) | 1991-11-16 | 1993-05-27 | Cpc International Inc. | Cereal extracts |
| GB9208731D0 (en) * | 1992-04-22 | 1992-06-10 | Squibb & Sons Inc | Hydrocolloid wound gel |
| US5460957A (en) * | 1992-04-28 | 1995-10-24 | Maruha Corporation | Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate |
| IT1263394B (it) * | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati |
| US5670169A (en) * | 1993-12-20 | 1997-09-23 | E.R. Squibb & Sons, Inc. | Wound hydrating gel with novel preservative system and low cytotoxicity |
| GB9401279D0 (en) * | 1994-01-24 | 1994-03-23 | Bristol Myers Squibb Co | Wound dressing |
| US6080420A (en) * | 1994-09-29 | 2000-06-27 | Advanced Medical Solutions Limited | Fibres of cospun alginates |
| GB9421653D0 (en) * | 1994-10-27 | 1994-12-14 | Innovative Tech Ltd | Wound dressing |
| WO1997003710A1 (en) * | 1995-07-19 | 1997-02-06 | Innovative Technologies Limited | Wound treatment composition |
-
1997
- 1997-03-07 GB GB9704807A patent/GB2322864A/en not_active Withdrawn
-
1998
- 1998-03-05 ES ES98908193T patent/ES2206899T3/es not_active Expired - Lifetime
- 1998-03-05 DK DK98908193T patent/DK0968009T3/da active
- 1998-03-05 JP JP53931998A patent/JP2002501406A/ja not_active Ceased
- 1998-03-05 WO PCT/GB1998/000494 patent/WO1998040110A1/en active IP Right Grant
- 1998-03-05 CA CA002283483A patent/CA2283483C/en not_active Expired - Fee Related
- 1998-03-05 AU AU66278/98A patent/AU6627898A/en not_active Abandoned
- 1998-03-05 DE DE69817782T patent/DE69817782T2/de not_active Expired - Lifetime
- 1998-03-05 EP EP98908193A patent/EP0968009B1/de not_active Expired - Lifetime
- 1998-03-06 ZA ZA9801908A patent/ZA981908B/xx unknown
-
1999
- 1999-08-26 US US09/383,643 patent/US6251424B1/en not_active Expired - Lifetime
- 1999-09-01 NO NO19994242A patent/NO319583B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69817782D1 (de) | 2003-10-09 |
| CA2283483C (en) | 2007-05-29 |
| NO994242D0 (no) | 1999-09-01 |
| US6251424B1 (en) | 2001-06-26 |
| EP0968009A1 (de) | 2000-01-05 |
| DE69817782T2 (de) | 2004-07-01 |
| ZA981908B (en) | 1998-05-22 |
| GB9704807D0 (en) | 1997-04-23 |
| JP2002501406A (ja) | 2002-01-15 |
| NO994242L (no) | 1999-11-08 |
| AU6627898A (en) | 1998-09-29 |
| CA2283483A1 (en) | 1998-09-17 |
| ES2206899T3 (es) | 2004-05-16 |
| DK0968009T3 (da) | 2003-12-29 |
| WO1998040110A1 (en) | 1998-09-17 |
| EP0968009B1 (de) | 2003-09-03 |
| GB2322864A (en) | 1998-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6174690B2 (ja) | ヒアルロン酸に基づく組成物の調製方法 | |
| CN102698313B (zh) | 一种纳米银抗菌水凝胶及其制备方法 | |
| US20030148994A1 (en) | Hemostatic composition | |
| US6258995B1 (en) | Wound treatment composition | |
| CN103394116B (zh) | 一种可促进伤口愈合的水凝胶敷料及其制备方法 | |
| AU2005259789A1 (en) | Non-adhesive hydrogels | |
| CN109106974B (zh) | 凝胶组织封堵材料及其制备方法和封堵制品 | |
| EP3318278B1 (de) | Pharmazeutische zusammensetzungen mit collagen und natriumhyaluronat | |
| JPH04505267A (ja) | 薬物学的調製物におけるまたは関する改良点 | |
| Sharma et al. | Borax mediated synthesis of a biocompatible self-healing hydrogel using dialdehyde carboxymethyl cellulose-dextrin and gelatin | |
| WO2016155749A1 (ru) | Кровоостанавливающее и ранозаживляющее средство | |
| US10967097B1 (en) | Methods of making chitosan/hyaluronic acid hydrogel compositions and compositions made therefrom | |
| NO319583B1 (no) | Gel for sarbehandling og fremstilling av denne | |
| RU2249467C2 (ru) | Медицинский материал и изделия на его основе | |
| WO2009043839A1 (en) | Coalescing carboxymethylchitosan-based materials | |
| JP2004059926A (ja) | デンプンハイドロゲル | |
| JP4044291B2 (ja) | 水膨潤性高分子ゲルおよびその製造法 | |
| CZ302380B6 (cs) | Suchá substance hydrogelu pro krytí ran a zpusob její prípravy | |
| RU2194535C2 (ru) | Средство для лечения ран | |
| CN108463256A (zh) | 生物可降解的植入物 | |
| JP6433828B2 (ja) | 感圧性ヒドロゲルおよび使用方法 | |
| WO2022132136A1 (en) | Methods of making chitosan/hyaluronic acid hydrogel compositions and compositions made therefrom | |
| JP2024502880A (ja) | ヒアルロン酸、ポリエチレングリコール、及びシリコーン含有成分を含む生体適合性ヒドロゲル | |
| WO2020021499A1 (en) | Haemostatic gel composition and its process of preparation | |
| SE2350131A1 (en) | Wound hydrogel for managing acute and chronic wounds in human and animals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |